PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $441,000 | -51.1% | 11,002 | -54.5% | 0.07% | -45.5% |
| Q1 2022 | $902,000 | +40.7% | 24,164 | +40.2% | 0.12% | +86.2% |
| Q3 2021 | $641,000 | +58.7% | 17,239 | +101.9% | 0.06% | -3.0% |
| Q1 2021 | $404,000 | +42.3% | 8,540 | +44.4% | 0.07% | +103.0% |
| Q4 2019 | $284,000 | -75.5% | 5,914 | -80.8% | 0.03% | -72.0% |
| Q1 2019 | $1,161,000 | +45.9% | 30,832 | +32.9% | 0.12% | +28.3% |
| Q4 2018 | $796,000 | -40.9% | 23,200 | -19.1% | 0.09% | +24.3% |
| Q3 2018 | $1,348,000 | +202.9% | 28,690 | +18.1% | 0.07% | +155.2% |
| Q2 2017 | $445,000 | +45.0% | 24,300 | +111.5% | 0.03% | +93.3% |
| Q3 2015 | $307,000 | -89.2% | 11,487 | -80.6% | 0.02% | -86.4% |
| Q2 2015 | $2,853,000 | +96.2% | 59,274 | +148.1% | 0.11% | +89.7% |
| Q1 2015 | $1,454,000 | – | 23,889 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |